BIO-TECHNE CORP (TECH) Stock Fundamental Analysis
USA - NASDAQ:TECH - US09073M1045 - Common Stock
59.38 USD
-1.37 (-2.26%)
59.38 USD
0 (0%)
Overall TECH gets a fundamental rating of 6 out of 10. We evaluated TECH against 58 industry peers in the Life Sciences Tools & Services industry. TECH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. TECH has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
TECH had positive earnings in the past year.
In the past year TECH had a positive cash flow from operations.
Each year in the past 5 years TECH has been profitable.
Each year in the past 5 years TECH had a positive operating cash flow.
1.2 Ratios
TECH has a better Return On Assets (3.04%) than 74.14% of its industry peers.
The Return On Equity of TECH (3.91%) is better than 74.14% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.33%, TECH belongs to the top of the industry, outperforming 84.48% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for TECH is below the industry average of 13.50%.
The 3 year average ROIC (9.00%) for TECH is below the current ROIC(9.33%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.04% | ||
| ROE | 3.91% | ||
| ROIC | 9.33% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
1.3 Margins
The Profit Margin of TECH (6.32%) is better than 74.14% of its industry peers.
In the last couple of years the Profit Margin of TECH has declined.
TECH has a better Operating Margin (22.13%) than 91.38% of its industry peers.
TECH's Operating Margin has been stable in the last couple of years.
TECH has a better Gross Margin (66.83%) than 89.66% of its industry peers.
In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.13% | ||
| PM (TTM) | 6.32% | ||
| GM | 66.83% |
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
TECH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TECH has been reduced compared to 1 year ago.
Compared to 5 years ago, TECH has more shares outstanding
Compared to 1 year ago, TECH has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 11.78 indicates that TECH is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 11.78, TECH belongs to the best of the industry, outperforming 94.83% of the companies in the same industry.
TECH has a debt to FCF ratio of 1.34. This is a very positive value and a sign of high solvency as it would only need 1.34 years to pay back of all of its debts.
TECH has a Debt to FCF ratio of 1.34. This is amongst the best in the industry. TECH outperforms 89.66% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that TECH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.15, TECH is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.34 | ||
| Altman-Z | 11.78 |
ROIC/WACC0.91
WACC10.26%
2.3 Liquidity
A Current Ratio of 4.22 indicates that TECH has no problem at all paying its short term obligations.
The Current ratio of TECH (4.22) is better than 65.52% of its industry peers.
TECH has a Quick Ratio of 2.81. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of TECH (2.81) is better than 60.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.22 | ||
| Quick Ratio | 2.81 |
3. Growth
3.1 Past
TECH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.82%.
The Earnings Per Share has been growing by 11.25% on average over the past years. This is quite good.
The Revenue for TECH has decreased by -16.00% in the past year. This is quite bad
TECH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.55% yearly.
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%
3.2 Future
Based on estimates for the next years, TECH will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.61% on average per year.
Based on estimates for the next years, TECH will show a small growth in Revenue. The Revenue will grow by 7.10% on average per year.
EPS Next Y5.89%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
EPS Next 5Y8.61%
Revenue Next Year1.85%
Revenue Next 2Y4.68%
Revenue Next 3Y5.9%
Revenue Next 5Y7.1%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 30.77, the valuation of TECH can be described as expensive.
TECH's Price/Earnings ratio is a bit cheaper when compared to the industry. TECH is cheaper than 65.52% of the companies in the same industry.
TECH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 25.96, which means the current valuation is very expensive for TECH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 72.41% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of TECH to the average of the S&P500 Index (34.59), we can say TECH is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.77 | ||
| Fwd PE | 25.96 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TECH is valued a bit cheaper than 65.52% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TECH is valued a bit cheaper than the industry average as 63.79% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.26 | ||
| EV/EBITDA | 25.61 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
TECH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.22
PEG (5Y)2.73
EPS Next 2Y8.87%
EPS Next 3Y9.27%
5. Dividend
5.1 Amount
With a yearly dividend of 0.53%, TECH is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.48, TECH pays a better dividend. On top of this TECH pays more dividend than 93.10% of the companies listed in the same industry.
With a Dividend Yield of 0.53, TECH pays less dividend than the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
5.2 History
The dividend of TECH has a limited annual growth rate of 0.11%.
TECH has been paying a dividend for at least 10 years, so it has a reliable track record.
TECH has decreased its dividend recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
TECH pays out 65.26% of its income as dividend. This is not a sustainable payout ratio.
TECH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP65.26%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
59.38
-1.37 (-2.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners103.36%
Inst Owner Change-2.57%
Ins Owners0.26%
Ins Owner Change3.89%
Market Cap9.24B
Revenue(TTM)1.22B
Net Income(TTM)76.84M
Analysts81.74
Price Target67.89 (14.33%)
Short Float %4.47%
Short Ratio3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP65.26%
Div Incr Years0
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.05%
Min EPS beat(2)-2.04%
Max EPS beat(2)4.14%
EPS beat(4)3
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)5
Avg EPS beat(8)2.5%
EPS beat(12)5
Avg EPS beat(12)-1.36%
EPS beat(16)7
Avg EPS beat(16)-2.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-1.54%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-2.41%
Revenue beat(16)4
Avg Revenue beat(16)-2.23%
PT rev (1m)1.36%
PT rev (3m)-0.31%
EPS NQ rev (1m)-0.57%
EPS NQ rev (3m)-4.64%
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-3.72%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)-2.85%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-3.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.77 | ||
| Fwd PE | 25.96 | ||
| P/S | 7.6 | ||
| P/FCF | 41.26 | ||
| P/OCF | 36.8 | ||
| P/B | 4.7 | ||
| P/tB | 14.52 | ||
| EV/EBITDA | 25.61 |
EPS(TTM)1.93
EY3.25%
EPS(NY)2.29
Fwd EY3.85%
FCF(TTM)1.44
FCFY2.42%
OCF(TTM)1.61
OCFY2.72%
SpS7.82
BVpS12.63
TBVpS4.09
PEG (NY)5.22
PEG (5Y)2.73
Graham Number23.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.04% | ||
| ROE | 3.91% | ||
| ROCE | 11.3% | ||
| ROIC | 9.33% | ||
| ROICexc | 9.93% | ||
| ROICexgc | 24.48% | ||
| OM | 22.13% | ||
| PM (TTM) | 6.32% | ||
| GM | 66.83% | ||
| FCFM | 18.41% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score5
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.34 | ||
| Debt/EBITDA | 0.8 | ||
| Cap/Depr | 25.63% | ||
| Cap/Sales | 2.24% | ||
| Interest Coverage | 14.5 | ||
| Cash Conversion | 66.94% | ||
| Profit Quality | 291.58% | ||
| Current Ratio | 4.22 | ||
| Quick Ratio | 2.81 | ||
| Altman-Z | 11.78 |
F-Score5
WACC10.26%
ROIC/WACC0.91
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
EPS Next Y5.89%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
EPS Next 5Y8.61%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%
Revenue Next Year1.85%
Revenue Next 2Y4.68%
Revenue Next 3Y5.9%
Revenue Next 5Y7.1%
EBIT growth 1Y-10.6%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year17.25%
EBIT Next 3Y11.13%
EBIT Next 5Y8.56%
FCF growth 1Y3.97%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-2.5%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%
BIO-TECHNE CORP / TECH FAQ
Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?
ChartMill assigns a fundamental rating of 6 / 10 to TECH.
What is the valuation status for TECH stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.
How profitable is BIO-TECHNE CORP (TECH) stock?
BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.
How financially healthy is BIO-TECHNE CORP?
The financial health rating of BIO-TECHNE CORP (TECH) is 8 / 10.
What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?
The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 5.89% in the next year.